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Talin is believed to be one of the key proteins involved in
linking actin filaments to extracellular matrix receptors
in focal adhesions. Our strategy for studying the
function of talin has been to inactivate talin in living
fibroblasts in tissue culture through the microinjection
of affinity-purified, polyclonal anti-talin antibodies. The
effect of the injected anti-talin antibodies on cell
spreading was found to depend on how recently the cells
had been plated. Cells that were in the process of
spreading on a fibronectin substratum, and which had
newly developed focal adhesions, were induced to round
up and to disassemble many of the adhesions. However,
if fibroblasts were allowed to spread completely before
they were microinjected with the anti-talin antibody,
focal adhesions remained intact and the flat morphology
of the cells was unaffected. The percentage of cells that
were able to maintain a spread morphology despite the
injection of anti-talin antibodies increased during the
first few hours after plating on fibronectin substrata.
Fibroblasts that were allowed to spread completely
before microinjection with the anti-talin antibody
retained both intact focal adhesions and a flat, well-
spread morphology, but failed to migrate effectively.
Our experiments do not directly address the role of talin
in mature focal adhesions, but they indicate that talin is
essential for the spreading and migration of fibroblasts
on fibronectin as well as for the development and initial
maintenance of focal adhesions on this substratum.
Key words: focal adhesions, vinculin, microinjection, talin,
migration.
Introduction
Cells in culture typically adhere to the substratum
through two different types of adhesion, known as focal
adhesions (focal contacts) and close contacts (Izzard
and Lochner, 1976). These two types of adhesion can be
distinguished using interference reflection microscopy
(IRM). Focal adhesions appear as discrete areas that
are dark gray or black, indicating a separation between
the ventral plasma membrane and the substratum of 10-
15 nm, whereas close contacts appear as broad regions
that are lighter gray and represent a separation of about
30 nm. At their cytoplasmic face, focal adhesions are
associated with the ends of bundled actin filaments that
make up stress fibers, whereas close contacts are
associated with cross-linked networks of actin filaments
(Heath and Dunn, 1978). Tension generated by stress
fibers is transmitted across the plasma membrane to the
substratum at sites of focal adhesion, and proteins that
concentrate at these sites may serve as links between
actin filaments and extracellular matrix (ECM) com-
ponents (for review see Burridge et al., 1988). In
contrast, little is known about the organization or
composition of close contacts. Functionally, close
contacts have been correlated with migratory activity
and they are more prominent in rapidly locomoting
cells (Couchman and Rees, 1979; Kolega et al., 1982).
Talin is a cytoskeletal protein that is concentrated in
focal adhesions (Burridge and Connell, 1983; Hock et
al., 1989) along with a number of other proteins.
Various interactions between focal adhesion proteins in
vivo have been proposed, based on the results of in vitro
binding studies. For example, talin binds to ECM
receptors of the integrin family (Horwitz et al., 1986),
to the focal adhesion protein vinculin (Otto, 1983;
Wilkins et al., 1983; Burridge and Mangeat, 1984) and
also to actin (Muguruma et al., 1990). These interac-
tions suggest that talin may function either as a direct
link between integrins and actin or indirectly through its
interaction with vinculin, which in turn has been shown
to bind the actin-binding protein a-actinin (Belkin and
Koteliansky, 1987; Wachsstock et al., 1987). However,
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other potential linkages are also suggested by in vitro
binding experiments. a'-Actinin, for example, has also
been shown to bind to integrins directly (Otey et al.,
1990b); and tensin has been reported to bind both actin
and vinculin (Wilkins et al., 1987). The results of in
vitro binding experiments provide important clues to
both the interactions and the functions of these proteins
inside cells. Nevertheless, confirming these functions
will be difficult. We have performed three distinct
assays to analyze the function of talin in living
fibroblasts cultured on fibronectin. We have micro-
injected anti-talin antibodies into well-spread fibro-
blasts with mature focal adhesions. We have injected
the antibodies into spreading fibroblasts that had only
newly formed focal adhesions, and we have injected the
antibodies into fibroblasts with mature focal adhesions
that were induced to migTate by the wounding of a
confluent monolayer. We found that the microinjection
of these antibodies could inhibit fibroblast migration
and spreading, two processes that involve the formation
of new focal adhesions. Furthermore, we found that the




Chicken embryo dermal fibroblasts (CEF) were isolated from
8- to 12-day-old embryos as described previously (Duband et
al., 1988). CEF were grown in Dulbecco's modified Eagle's
medium (DMEM) containing 10% fetal bovine serum (FBS),
15 mM HEPES (pH 7.4), 100 i.u./ml penicillin and 100 /ig/ml
streptomycin (pen/strep) in a 37°C, 5% CO2 incubator.
Affinity purification of anti-talin antibodies and
preparation of control antibodies
Approximately 10 mg of talin, purified from chicken gizzard
as described by Molony et al. (1987), was dialyzed overnight
against a buffer of 20 mM NaCl, 20 mM MES, pH 7.4. The
talin was coupled to 2 ml Affigel 10 (BioRad, Richmond, CA)
following directions supplied by the manufacturer. Unreacted
sites on the Affigel were blocked with ethanolamine. The gel
was washed extensively with PBS~ (phosphate buffered saline
without Ca2+ or Mg2*) plus 0.1% NaN3. Approximately 3 ml
of rabbit anti-talin serum (characterized by Rochlin et al.,
1989) was centrifuged at 15,000 g for 15 min and the
supernatant was diluted 1:1 with PBS~ plus NaN3 before
incubating with the talin-Affigel for 4 h at 4°C. After the
incubation, the gel was packed by centrifugation at 300g for 3
min and the supernatant was removed.
The antiserum that was applied to the talin-Affigel beads
was routinely used to immunostain fibroblasts at a dilution of
1:5000; however, the supernatant from the talin-Affigel beads
gave no focal contact staining on CEF at a dilution of 1:10.
The IgG in this supernatant was used for control microinjec-
tions after it was concentrated by ammonium sulfate precipi-
tation and dialyzed against antibody injection buffer (75 mM
KG, 10 mM potassium phosphate buffer, pH 7.5).
The talin affinity column with antibody bound was washed
with 50 bed volumes of PBS" with 0.1% NaN3 and then
bound antibody was eluted with 100 mM triethylamine, pH
11.5, followed by a wash with 10 bed volumes of PBS~. After
washing, the column was further eluted with 100 mM glycine-
HC1, pH 2.6. Peak fractions from each of these elutions were
pooled and concentrated by dialysis against sucrose, followed
by extensive dialysis against antibody injection buffer. The
final sample of affinity-purified anti-talin was determined to
be 3 mg/ml by spectrophotometric measurements. At a
dilution of 1:10,000, this antibody stained a typical focal
adhesion pattern in fibroblasts (data not shown).
Antibody microinjection
Coverslips were incubated with 50 /ig/ml human plasma
fibronectin (New York Blood Center, New York) in PBS+
(PBS with Ca2+ and Mg2*) for 30 min at 37°C followed by a
brief wash with PBS+. CEF, after several passages in tissue
culture were plated onto these coated coverslips in complete
medium. Depending on the experiment, CEF plated onto
fibronectin-coated coverslips were incubated for 15 min to 12
h (pre-injection incubation). CEF used for migration exper-
iments were cultivated on fibronectin-coated coverslips for a
24-h pre-injection incubation, and the entire CEF population
was then removed from one half of the slide with a cell
scraper. At the end of the pre-injection incubation, the
coverslips for all experiments were transferred to warm,
gassed, fresh medium for microinjection.
Cells were microinjected using the method described by
Graessmann et al. (1980). Experimental and control injec-
tions were performed on the same coverslip. A diamond
scribe was used to scratch a circle and a square on each
coverslip. Cells within the circle were microinjected with
affinity-purified anti-talin antibodies, and cells within the
square with control antibodies all using essentially identical
Kwik-fil glass capillaries (World Precision Instruments, New
Haven, CT) pulled on a Brown-Flaming micropipette puller
(Sutter Instrument Co., San Francisco, CA). The length of
the needles was minimized to prevent loss of antibody due to
adsorption to the glass during loading; most needles were
approximately 2 cm in length. Microinjection was performed
on a Leitz Diavert microscope using a x32 phase-contrast
objective and a Leitz micromanipulator. After the injections,
the coverslips were returned to the incubator for a 2- to 3-h
post-injection incubation or in one experiment that tested the
cells' ability to recover from the anti-talin antibody micro-
injection there was a 43-h incubation.
For the migration experiments, experimental and control
injections were performed on separate, paired coverslips.
Only the cells immediately adjacent to the wound edge
created by the cell scraper were injected. These coverslips
then received a 12-h post-injection incubation to allow
recovery and migration into the denuded one half of the
coverslip.
Immunostaining and microscopy
Coverslips were fixed prior to permeabilization and immuno-
staining using protocols described previously (Nuckolls et al.,
1990). Immunostaining for talin was performed using either a
monoclonal, mouse anti-talin antibody characterized pre-
viously (Otey et al., 1990a), or the rabbit anti-talin serum used
for affinity preparations. Immunostaining of vinculin was
accomplished using a monoclonal anti-chicken vinculin anti-
body that was developed in this laboratory. Secondary
antibodies were an FTTC-conjugated, species cross-adsorbed,
donkey anti-rabbit IgG (Jackson Immuno-research Lab.,
West Grove, PA) diluted in PBS+ to 1:100 or a TRITC-
conjugated goat anti-mouse IgG (Cappel, Malvern, PA)
diluted in PBS+ to 1:50. Actin stress fibers were stained using
rhodamine-conjugated phalloidin (Molecular Probes,
Eugene, OR). After a final wash, the coverslips were rinsed in
deionized water and mounted in 10% Mowiol (Calbiochem,
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San Diego, CA) in a Tris buffer, pH 8.5, and air dried. For
interference reflection microscopy (IRM), the well of a
hanging-drop mount slide was filled with 50% glycerol in
PBS", 0.1% NaN3, pH 8.5. The coverslips were inverted and
mounted in the glycerol solution and sealed with silicon
grease. Fluorescence images were photographed onto TMAX
400 or P3200 film with Zeiss Planapo x63 or Plan-Neofiuar
x40 or x20 objective lenses. IRM images were photographed
through a Zeiss Antiflex x63 objective on Kodak Technical
Pan 2415 film developed with D19.
To verify that cells had survived the microinjection,
selected coverslips were incubated with 5 /Jvl propidium
iodide in DMEM prior to fixation according to the method
described by Lemasters et al. (1987). After viewing the areas
of the coverslip that had been microinjected with anti-talin or
control antibodies, any cells that had taken up the vital stain
were photographed, and then these coverslips were fixed and
immunostained to identify the cells that contained injected
antibody.
Results
Injection of fully spread fibroblasts with anti-talin
CEF were plated on glass coverslips 12 h prior to
microinjection. Cells on the coverslip were injected
with affinity-purified, polyclonal rabbit anti-chicken
talin antibodies at a concentration of 3 mg/ml or with
control antibodies at equal or higher concentrations.
Injections were estimated to be 10-20% of the volume
of the cell (about 10~7 [A injected per cell). The
coverslips were incubated for 3 h after the injection to
allow for the antibodies to gain access to all parts of the
injected cells. The cells were then fixed and immuno-
stained with a fluorescent anti-rabbit antibody to
localize the injected antibody, and vinculin or talin was
localized in the same cells using monoclonal antibodies
and indirect immunofluorescence. Interference reflec-
tion microscopy (IRM) and immunostaining demon-
strated that anti-talin antibodies injected into fibro-
blasts decorated structures containing talin. Fig. 1
demonstrates the localization of anti-talin antibodies
microinjected into a well-spread fibroblast. The injected
antibody localized to focal adhesions (arrow in Fig. IB)
that were also sites of concentration of the protein
vinculin (arrow in Fig. 1C). The corresponding IRM
image (Fig. 1A) demonstrated that focal adhesions
appeared normal and a well-spread morphology was
maintained in these cells. The injected antibody also
labelled a fibnllar pattern that is only weakly labelled
with antibodies against vinculin. This pattern is similar
to the distribution of talin in many cells when talin
aligns with ECM components such as fibronectin
(Burridge and Connell, 1983). Injected cells continued
to display normal patterns of stress fibers (data not
shown). Control injected antibodies were distributed
diffusely throughout the cytoplasm and were excluded
from the nucleus (see Fig. 3B, below).
Anti-talin injected into spreading cells
Since the injection of anti-talin did not perturb
fibroblasts that were completely spread and had mature
adhesions, we investigated whether the antibody would
affect cell spreading. Prior to these experiments we
evaluated the spreading of CEF on different substrata:
untreated glass coverslips, serum-treated coverslips and
coverslips coated with fibronectin. Spreading was
fastest and most consistent on the fibronectin-coated
coverslips (our unpublished results). Consequently, we
used fibronectin-coated coverslips for all the spreading
experiments. CEF were trypsinized, washed and plated
onto fibronectin-coated coverslips. Cells that have been
Fig. 1. Microinjection of anti-talin antibodies into well-spread fibroblasts. CEF were plated onto coverslips for 12 h and
then microinjected with the anti-talin antibody. The cells were fixed 2 h after the microinjection and immunostained for the
injected antibody (B) and for vinculin (C). A portion of a cell that has not been injected with the anti-talin antibody is
seen in the upper left corner of two of the images. Cells displayed numerous focal adhesions (arrows) visualized by
interference reflection microscopy (A), which are characteristic of well-spread CEF. The injected antibodies concentrated
at these sites but did not appear to disrupt them. The injected antibody also localized in fibrillar streaks that stain weakly
for vinculin, and are not seen in the IRM image (arrowhead in B). Vinculin distribution appears unaffected by anti-talin
injection. Bar, 20 /«n.
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Fig. 2. Adhesions of fibroblasts during cell spreading. CEF were plated onto fibronectin-coated coverslips and incubated for
30 min. The cells were then fixed and immunostained for talin (B) and vinculin (C). The IRM image (A) reveals small,
dot-like focal adhesions (arrowhead), as well as broad areas of focal adhesion (double arrowhead). Talin is concentrated in
focal adhesions and at the cell's margin. Vinculin is concentrated in focal adhesions, but is less prominent than talin at the
cell's margin. Bar, 20 jan.
spreading for 30 min on fibronectin-coated coverslips
exhibit several structures that contribute to the ad-
hesions of these cells (Fig. 2). The IRM image (Fig. 2A)
shows small dot-like focal adhesions (arrowhead) as
well as broad areas of focal adhesion (double arrow-
head). Although there are some regions of close
contact, the predominant adhesions are focal. Talin is
concentrated in the focal adhesions, and is also found at
the cell margin (Fig. 2B). Vinculin is concentrated in
the focal adhesions, but, as described previously
(Burridge and Connell, 1983; Izzard, 1988), it is not as
prominent at the cell margin as talin (Fig. 2C).
Fig. 3A shows a sample field of CEF that were
allowed to spread on fibronectin-coated coverslips for
30 min before injecting the cells with anti-talin
antibody. After the 3-h post-injection incubation, the
Fig. 3. The effects of the anti-talin antibody microinjection on spreading fibroblasts. After 30 min of spreading on
fibronectin, CEF were microinjected with affinity-purified polyclonal anti-talin (A), or a control antibody (B). Two hours
after the injection, cells were fixed and the microinjected antibodies were localized. The anti-talin antibody caused most
cells to round up while control injected cells spread out and exhibited a normal fibroblast morphology. The arrow in A
indicates a cell that has been affected by the anti-talin injection but, according to the criteria used, this cell would be
classified as spread, since it has visible cell extensions. Bar, 50 fan.
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cells were fixed and a fluorescent secondary antibody
was applied. The injection of anti-talin not only
inhibited cell spreading, but reversed the spreading that
had occurred during the 30 min of incubation prior to
microinjection. In parallel, cells on the same coverslip
were microinjected with a control antibody (Fig. 3B).
Unlike cells injected with anti-talin, the cells injected
with a control antibody spread out normally and
displayed a morphology indistinguishable from non-
injected cells. The cells injected with control antibodies
contained normal stress fibers and formed focal ad-
hesions that were sites of talin concentration (data not
shown).
Examples of cells rounded by injection of talin
antibodies are shown in Fig. 4 at higher magnification.
These cells have been stained to visualize the injected
antibody (Fig. 4A and D) and the distribution of actin
(Fig. 4B and E). The adhesions to the substratum have
been visualized by IRM (Fig. 4C and F). The injected
antibody is visible as brightly staining precipitates in
both cells, but in Fig. 4D there is also a diffuse
distribution of antibody superimposed on this pattern,
probably indicating an excess of antibody in the
cytoplasm and that this cell received relatively more
than the cell in Fig. 4A. It is notable that this cell lacks
any discernible stress fibers (Fig. 4E) and has very few
adhesions visible by IRM (Fig. 4F). The cell in the top
Fig. 4. Stress fibers and
adhesions were perturbed by
the injection of anti-talin
antibodies into spreading
fibroblasts. The localization of
injected anti-talin antibodies
(A and D) shows extensive
precipitates in the injected
cells. Rhodamine-phalloidin
staining (B and E) reveals a
reduced number or absence of
stress fibers in the injected
cells. IRM images (C and F)
demonstrate that the anti-talin
injections have abolished most
of the focal adhesions. Bar,
20/im.
panel shows a few residual adhesions and stress fibers,
particularly at the periphery of the cell. It is interesting
that the antibody is also concentrated along the margin
of the cell coincident with these few stress fibers and
some of the adhesions. In comparison with the
noninjected cells in these images, however, this cell has
diminished stress fibers and much smaller, less-promi-
nent focal adhesions.
Quantitation of the effects of anti-talin injection
As was shown in Fig. 1, CEF that had been adhering to
coverslips overnight did not change their morphology
when injected with anti-talin antibody, but cells that
were in the process of spreading on coverslips became
rounded by the injection of anti-talin (Fig. 3). To
quantitate the effects of the microinjection of anti-talin
throughout the period of focal adhesion formation and
maturation, CEF were plated onto fibronectin-coated
coverslips and given pre-injection incubations of 30 min
to 12 h. The cells in one area of each coverslip were
microinjected with the anti-talin antibody, while cells in
an adjacent area of each coverslip were injected with
the control antibody. At the end of the post-injection
incubation, the coverslips were fixed and the injected
antibodies were immunolocalized. Using a low-magnifi-
cation objective lens, fluorescence and phase-contrast
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Fig. 5. Several hours after plating, CEF become resistant
to the injected anti-talin antibody. CEF were plated onto
fibronectin-coated coverslips and incubated for 30 min, 1 h,
2 h, 4 h or 12 h, and were then microinjected with the
anti-talin antibody, or the control antibody. Experimental
and control injections were performed on adjacent areas of
the same coverslips. After a 3 h post-injection incubation,
the cells were fixed and a fluorescent secondary antibody
was applied. Phase-contrast and fluorescence microscopy
images were compared, and each cell containing a
detectable amount of injected antibody was classified as
either round or spread.
images of relevant areas of the coverslips were
compared. Although the morphologies of anti-talin- or
control-injected cells varied, for the purpose of these
experiments, cells containing the microinjected anti-
bodies were classified simply as either round or spread,
and the number of cells of each type of morphology was
tallied. A cell was scored as spread if it displayed a thin
lamella or if it had cell processes detectable at low
magnification that were at least twice as long as the cell
body. Cells lacking these structures were classified as
round and were most often surrounded by a phase-light
region. According to these criteria, at the time of
microinjection essentially all cells were spread. There-
fore, a rounded morphology at the end of the post-
injection incubation indicates not only an inhibition of
spreading, but a reversal of spreading in that cell.
The combined data from such experiments are shown
in Fig. 5. In cells injected after a 30-min pre-injection
incubation, and examined 3 h later, 26% of the cells on
the coverslip that contained detectable amounts of the
anti-talin antibody (rc=156) displayed a spread mor-
phology after the post-injection incubation. By com-
parison, 86.5% of cells containing detectable amounts
of control antibody («=148) or 87% of non-injected
cells on the same coverslip (rc=255) displayed a spread
morphology after the post-injection incubation. In cells
that were injected after an hour of spreading, the
percentage of anti-talin-injected cells that were able to
maintain the flat morphology increased to 46% (n=60).
The increased pre-injection incubation did not affect
the morphology of control-injected cells, of which 88%
were spread (n=146). When the pre-injection incu-
bation was increased to 2 h, the percentage of anti-talin-
injected cells that displayed a spread morphology after
the post-injection incubation increased to 58% (n=43).
91% of control injected cells (n=66) were spread in this
time course. By 12 h of pre-injection incubation, the
morphology of anti-talin-injected cells approached that
of control-injected, or non-injected cells.
It is important to note that cells displaying a rounded
morphology are more likely to be lost from the
coverslip during the process of fixation, permeabiliz-
ation and immunostaining than cells that have a spread
morphology. This phenomenon would tend to skew the
percentages, and so the actual difference between
control and experimental injected cells in experiments
with short pre-injection incubations may be greater
than that shown in Fig. 5.
Assessment of cell viability
CEF that had been plated on fibronectin-coated
coverslips for 30 min were microinjected, incubated for
3 h, and stained with the fluorescent vital dye propidium
iodide. None of the rounded cells in the area of the
coverslips that had been injected with the anti-talin
antibody were able to take up the dye. This indicated
that their plasma membranes were intact. The cover-
slips were then fixed and immunostained to localize the
injected antibody, which revealed that round cells that
contained talin immunoprecipitates were in fact cells
that had excluded the propidium iodide (data not
shown). There was a small percentage of dead, non-
injected cells on each coverslip that took up the
propidium iodide, and these cells served as controls for
the vital staining.
Experiments were also performed to determine
whether cells rounded by the injection of anti-talin
antibodies could recover from these effects. Two hours
after microinjecting anti-talin into all of the cells within
a scored area of the coverslip, an empty microinjection
needle was used to remove all of the spread cells within
the scored area. This left only rounded cells in the area
where cells had been injected with the anti-talin
antibody. The coverslip was transferred to a dish
containing fresh medium, and the cells were returned to
the incubator for an extended post-injection incubation.
At 43 h after microinjection, the coverslip was fixed and
a fluorescent secondary antibody was applied. Fig. 6
shows a representative cell from the scored area of the
coverslip. This cell shows some fibrillar staining and a
dense aggregate of anti-talin (Fig. 6B). The IRM image
of this cell that had been previously rounded with anti-
talin antibodies demonstrates that focal adhesions were
formed during the 43-h post-injection period (Fig. 6C).
Frequently the aggregate of antibody seen in the
fluorescence images of these cells could also be detected
in the phase-contrast images (arrowhead in Fig. 6A)
and often there were phase-dense granules, probably
lysosomes, associated with these aggregates. Cells
microinjected with the control antibody continued to
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Fig. 6. Recovery from anti-talin injection. CEF that had been injected with the anti-talin antibody and that were known to
have been rounded 2 h after the injection were incubated for an additional 41 h, and then fixed and stained for the injected
antibody. An aggregate of anti-talin was seen in most cells (B), and this aggregate could usually be correlated with a dense
structure (arrowhead) in the phase-contrast image (A) close to the nucleus. The IRM image (C) demonstrates that new























display a diffuse distribution of injected antibody after
43 h of post-injection incubation that was indistinguish-
able from the distribution of this antibody in equivalent
cells 3 h after injection (Fig. 3B).
Anti-talin effects on fibroblast migration
Since the microinjection of anti-talin antibody affected
focal adhesion formation in spreading fibroblasts, we
studied the impact of anti-talin on fibroblast migration,
another activity requiring the formation of adhesions.
CEF were plated on fibronectin-coated coverslips at
confluent density, and incubated in complete medium
for 24 h. The entire population of CEF was then cleared
from one half of the coverslip with a plastic cell scraper,
leaving a straight-edged wound margin to serve as a
starting baseline for cell migration. Separate coverslips
were then used to study the effects of either anti-talin
antibody or control antibody on fibroblast migration by
injecting cells that were immediately adjacent to the
wound edge. Following a 12-h post-injection incu-
bation, cells were fixed, permeabilized and immuno-
stained with a fluorescein-conjugated anti-rabbit anti-
body to identify injected cells, as well as with
rhodamine-conjugated phalloidin to visualize all of the
cells on the coverslip. Injected cells were then counted
and their migration behavior categorized with one of
the following three descriptions: remaining at the
starting baseline of the wound edge; leaving the wound
edge to join the migrating pack of cells; or taking a
position at the leading edge of the cells migrating into
the denuded half of the coverslip. A complete tabula-
tion of the data from the 349 cells injected in these
experiments is summarized in Table 1. In the group
injected with anti-talin antibodies (n=195), only 19% of
the injected cells left the baseline of the wound edge to
join the migrating pack and none of these took a position
at the leading edge of the migrating cell front. In the
group injected with control antibodies (rc=154), less than
2% of the injected cells remained at the baseline of the
wound edge, while 53% took positions at the leading edge
of the migrating cell front, and the remaining 46% had
joined the migrating pack. Representative fields from the
anti-talin and control injection groups are shown in Fig. 7.
The cell injected with anti-talin antibodies (Fig. 7B) has
remained at the baseline of the wound edge (white
arrows), and is left behind by the migrating noninjected
cells in the same microscopic field that are stained with
rhodamine-phalloidin (Fig. 7A). Cells injected with
control antibodies (Fig. 7D) are shown migrating in
positions both at the leading edge and well into the
migrating pack and may be compared with noninjected
cells stained with rhodamine-phalloidin in the same
microscopic field (Fig. 7C).
Discussion
Talin is a prominent protein at the cytoplasmic face of
focal adhesions. Like many of the other cytoplasmic
components of focal adhesions, the function of talin has
not been established. The interaction of talin with both
integrins and actin in vitro (Horwitz et al., 1986;
Muguruma et al., 1990) together with its location in
focal adhesions, suggests a probable role for talin in
linking actin filaments to integrins clustered in the
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Fig. 7. The effects of anti-talin antibody microinjection on fibroblast migration. CEF were plated onto fibronectin-coated
coverslips for 24 h. The cell population was entirely cleared from one half of the coverslip with a cell scraper, and cells
immediately contiguous with the wound edge were microinjected with either anti-talin antibody or control antibody. After
an additional 12 h incubation the injected cells were revealed by staining with fluorescein-conjugated anti-rabbit antibody
(B and D), and rhodamine-conjugated phalloidin was used to stain all cells on the coverslip (A and C). Paired images of
the same microscopic field are displayed for the anti-talin (A and B) and control antibody (C and D) groups. The baseline
of the wound edge is marked (white arrows). The anti-talin-injected cell (B) does not migrate from the wound edge, and is
bypassed by noninjected neighboring cells that migrate into the denuded portion of the coverslip (A). Control antibody-
injected cells migrate away from the wound edge (D) as well as their noninjected neighbours (C). Bar, 100 jsm.
plasma membrane. In this paper we have attempted to
explore the function of talin by introducing affinity-
purified antibodies directed against talin into living
fibroblasts cultured on a fibronectin substratum. The
effects that we observed suggest that talin is essential
for focal adhesion formation and for the maintenance of
newly formed adhesions in fibroblasts grown on
fibronectin. In fully spread cells with mature focal
adhesions, the injected antibody localized to the focal
adhesions and fibrillar streaks. However, even with a
three hour incubation after antibody injection, the cells
remained spread and showed normal adhesions as
judged by IRM. In previous studies, the microinjection
of antibodies against vinculin failed to cause cell
rounding, although a partial loss of stress fibers and
focal adhesions was observed (Birchmeier et al., 1982;
Jockusch and Fuchtbauer, 1983; Westmeyer et al.,
1990). In another study, no noticeable effect on focal
adhesions or stress fibers was detected when antibodies
against either actin or a-actinin were injected into cells
(Jockusch and Fuchtbauer, 1983). These previous
studies used cells that were fully spread. In contrast,
when we introduced anti-talin antibodies into cells that
had been freshly plated and that were in the process of
spreading and forming new focal adhesions, the
spreading was inhibited and a large percentage of these
cells were caused to round up. Those cells that rounded
up lost focal adhesions and associated stress fibers. In
addition, the migration of well-spread fibroblasts with
mature focal adhesions was also inhibited by anti-talin
antibodies. A small percentage of cells were able to
spread out after injection of anti-talin in the cell
spreading assay. Similarly, a small percentage of cells
injected with anti-talin in the migration assay were able
to migrate away from the baseline. We suspect that this
represents variability in the amount of antibody
introduced into cells, and so immobilization of talin
may not have been complete in this small percentage of
cells. Our results indicate that talin is required for cells
to form new adhesions on fibronectin during cell
spreading and during migration.
During the first few minutes of adhesion and
spreading, the distribution of talin in fibroblasts
appears, by immunofluorescence, to be predominantly
as a soluble pool (G.H.N. unpublished results).
Detailed analysis of spreading margins of fibroblasts has
revealed two distinct sites of talin accumulation
(DePasquale and Izzard, 1991). Talin is concentrated in
nodes at the tips of F-actin-rich precursors of focal
adhesions, along the extreme edge of the spreading
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lamellipodium. Independent of its accumulation in
these nodes, talin also concentrates at newly formed
sites of adhesion between the substratum and the
plasma membrane. The injection of anti-talin into cells
that were spreading or migrating caused the formation
of immunoprecipitates within the cells. We suspect that
this precipitation of talin and its consequent depletion
from the soluble pool is the major block to the
formation of new focal adhesions. We have no evidence
that the antibody is able to interfere with the interaction
of talin with other proteins. In this regard, the antibody
failed to inhibit the interaction of talin with vinculin in
assays in vitro (data not shown).
The recruitment of talin from the soluble pool into
newly formed focal adhesions is likely to be a similar
process in both the cell spreading assay and the cell
migration assay. However, during cell migration, talin
in older focal adhesions near the rear of the cell is most
likely released into the soluble pool so that it can then
be involved in the formation of new adhesions at the
leading edge of the cell. The injected antibody may also
inhibit migration by binding and crosslinking talin in
existing focal adhesions, making these resistant to
disassembly as cells migrate.
An unexpected observation was that spreading cells
injected with anti-talin antibodies not only were
inhibited from further spreading, but frequently were
induced to round up. During this cell rounding the cells
disassembled focal adhesions that had already formed.
These newly formed adhesions thus appeared to be
more easily disrupted than the mature adhesions of
fully spread cells. The susceptibility of cells to agents
such as RGD-containing peptides and antibodies that
inhibit the interaction of integrins with their extracellu-
lar ligands also decreases as cells remain in culture (Neff
et al., 1982; Horwitz et al., 1984; Hayman et al., 1985).
This indicates that focal adhesions become more stable
with time in culture. Adhesions may be stabilized on the
extracellular face by the accumulation of secreted ECM
components. Inside the cell, more components may be
recruited to focal adhesions, and the complexity with
which these proteins interact may increase. In ad-
hesions developed during spreading and migration,
talin may be readily exchangeable with the soluble
pool, but it is likely to become more stably associated
with the focal adhesion as other proteins associate with
and crosslink talin. Consequently, the precipitation of
talin from the soluble pool may have little effect on talin
that has been stably incorporated into a mature
adhesion.
A second reason why the anti-talin antibodies have a
disruptive effect on immature adhesions but little or no
effect on mature adhesions may be that talin plays a
more essential role in the developing adhesions. Talin is
concentrated at the leading edge of fibroblasts (Bur-
ridge and Connell, 1983; Izzard, 1988; DePasquale and
Izzard, 1991) where new focal adhesions are formed
(Izzard and Lochner, 1980). In mature adhesions
parallel linkages between actin and the membrane may
exist that are not present in immature adhesions.
Consistent with this possibility, other work from this
laboratory has demonstrated an interaction between
the actin-binding protein u-actinin and integrin cyto-
plasmic domains (Otey et al., 1990b). It has been
suggested that ar-actinin may be more important in
bridging between actin filaments and integrins in
mature adhesions, whereas talin may be required for
the initial formation of the link between the cytoskel-
eton and the membrane in focal adhesions (Pavalko et
al., 1991). Our current data are consistent with such a
role for talin.
We thank Dr. Chris Turner and Dr. Fred Payalko for
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